Degradable magnesium-based implant devices for bone fixation

US2023381382A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023381382-A1
Application numberUS-202318204476-A
CountryUS
Kind codeA1
Filing dateJun 1, 2023
Priority dateAug 21, 2015
Publication dateNov 30, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to biodegradable, magnesium alloys, compositions and composites, methods for their preparation and applications for their use as implantable medical devices in load-bearing conditions. The magnesium alloys are composed of alloying elements selected from yttrium, calcium, zirconium, zinc, and strontium, with the remainder being magnesium and impurities arising due to production, and preparation of the alloy by melting together the elements and casting the resulting melted mixture. In certain embodiments, the methods of preparation include solution treatment and hot extrusion.

First claim

Opening claim text (preview).

In the claims: 1 . An orthopedic or craniofacial bone fixation component composed of an extruded biodegradable, magnesium alloy, consisting of: from 0.5 weight percent to 4.0 weight percent of yttrium; from greater than zero to 1.0 weight percent of zirconium; from greater than zero to 6.0 weight percent of strontium; and a balance of magnesium and impurities due to production, based on total weight of the alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod, and intramedullary pin. 2 . The bone fixation component of claim 1 , wherein the obtaining alloying elements comprises one or more alloy elements selected from the group consisting of: from about 1.0 weight percent to about 9.0 weight percent aluminum; from about 0.1 weight percent to about 1.0 weight percent of manganese; from about 0.25 weight percent to about 1.0 weight percent of silver; and from about 0.1 weight percent to about 1.0 weight percent of cerium. 3 . The bone fixation component of claim 1 , wherein the magnesium alloy comprises fluoride. 4 . A method of preparing an orthopedic or craniofacial bone fixation component, comprising: preparing a biodegradable, magnesium alloy, consisting of: from 0.5 weight percent to 4.0 weight percent of yttrium; from greater than zero to 1.0 weight percent of calcium; from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; from 0.10 weight percent to 6.0 weight percent of strontium; and a balance of magnesium and impurities due to production, based on total weight of the magnesium alloy; heating the metal alloy to form a molten magnesium alloy; casting the molten metal alloy to form a cast magnesium alloy; and extruding the cast metal alloy to form an extruded magnesium alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod, and intramedullary pin. 5 . The method of claim 4 , wherein the magnesium alloy further comprises one or more alloy elements selected from the group consisting of: from about 1.0 weight percent to about 9.0 weight percent aluminum; from about 0.1 weight percent to about 1.0 weight percent of manganese; from about 0.25 weight percent to about 1.0 weight percent of silver; and from about 0.1 weight percent to about 1.0 weight percent of cerium. 6 . The method of claim 4 , wherein the casting is selected from the group consisting of sand casting, gravity casting, permanent mold casting, direct chill casting, centrifugal casting, low/high pressure die casting, squeeze casting, continuous casting, vacuum casting, plaster casting, lost foam casting, investment casting, and lost wax casting. 7 . The method of claim 4 , wherein the extruding comprises hot extruding conducted at an extrusion ratio selected from 30:1 and 10:1. 8 . The method of claim 4 , further comprising homogenizing the cast magnesium alloy. 9 . The method of claim 4 , further comprising forming a fluoride coating on a surface of the extruded magnesium alloy. 10 . A method of preparing an orthopedic or craniofacial bone fixation component, comprising: preparing a biodegradable, magnesium alloy, consisting of: from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; and a balance of magnesium and impurities due to production, based on total weight of the alloy; heating the metal alloy to form a molten magnesium alloy; casting the molten metal alloy to form a cast magnesium alloy; and extruding the cast metal alloy to form an extruded magnesium alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod and intramedullary pin. 11 . The method of claim 10 , wherein the magnesium alloy further comprises one or more alloy elements selected from the group consisting of: from greater than zero to 6.0 weight percent of strontium; from about 1.0 weight percent to about 9.0 weight percent aluminum; from about 0.1 weight percent to about 1.0 weight percent of manganese; from about 0.25 weight percent to about 1.0 weight percent of silver; and from about 0.1 weight percent to about 1.0 weight percent of cerium. 12 . The method of claim 10 , wherein the casting is selected from the group consisting of sand casting, gravity casting, permanent mold casting, direct chill casting, centrifugal casting, low/high pressure die casting, squeeze casting, continuous casting, vacuum casting, plaster casting, lost foam casting, investment casting, and lost wax casting. 13 . The method of claim 10 , wherein the extruding comprises hot extruding conducted at an extrusion ratio selected from 30:1 and 10:1. 14 . The method of claim 10 , further comprising homogenizing the cast magnesium alloy. 15 . The method of claim 10 , further comprising forming a fluoride coating on a surface of the extruded magnesium alloy. 16 . A method of preparing an orthopedic or craniofacial bone fixation component, comprising: preparing a biodegradable, magnesium alloy, consisting of: from 0.5 weight percent to 4.0 weight percent of yttrium; from greater than zero to 1.0 weight percent of zirconium; from greater than zero to 6.0 weight percent of strontium; and a balance of magnesium and impurities due to production, based on total weight of the alloy; heating the metal alloy to form a molten magnesium alloy; casting the molten metal alloy to form a cast magnesium alloy; and extruding the cast metal alloy to form an extruded magnesium alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod, and intramedullary pin. 17 . The method of claim 16 , wherein the magnesium alloy further comprises one or more alloy elements selected from the group consisting of: from about 1.0 weight percent to about 9.0 weight percent aluminum; from about 0.1 weight percent to about 1.0 weight percent of manganese; from about 0.25 weight percent to about 1.0 weight percent of silver; and from about 0.1 weight percent to about 1.0 weight percent of cerium. 18 . The method of claim 16 , wherein the casting is selected from the group consisting of sand casting, gravity casting, permanent mold casting, direct chill casting, centrifugal casting, low/high pressure die casting, squeeze casting, continuous casting, vacuum casting, plaster casting, lost foam casting, investment casting, and lost wax casting. 19 . The method of claim 16 , wherein the extruding comprises hot extruding conducted at an extrusion ratio selected from 30:1 and 10:1. 20 . The method of claim 16 , further comprising homogenizing the cast magnesium alloy. 21 . The method of claim 4 , further comprising forming a fluoride coating on a surface of the extruded magnesium alloy.

Assignees

Inventors

Classifications

  • A61L31/148Primary

    Materials at least partially resorbable by the body · CPC title

  • Metals or alloys · CPC title

  • with zinc or cadmium as the next major constituent · CPC title

  • for reconstruction of bones; weight-bearing implants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023381382A1 cover?
The invention relates to biodegradable, magnesium alloys, compositions and composites, methods for their preparation and applications for their use as implantable medical devices in load-bearing conditions. The magnesium alloys are composed of alloying elements selected from yttrium, calcium, zirconium, zinc, and strontium, with the remainder being magnesium and impurities arising due to produc…
Who is the assignee on this patent?
Univ Pittsburgh Commonwealth Sys Higher Education
What technology area does this patent fall under?
Primary CPC classification A61L31/148. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).